Drupal.behaviors.print = function(context) {window.print();window.close();}>
Clavis Pharma Taps Skyline Dx for Array-based Patient Selection in AML Drug Trial
September 06, 2011
Clavis Pharma Taps Skyline Dx for Array-based Patient Selection in AML Drug Trial
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Skyline Dx, Janssen Partner on Adverse Reaction Risk Test for Multiple Myeloma Drug
July 26, 2011 / BioArray News
Skyline Dx Partners with LabPMM to Offer Array-based AML Testing Service in Europe
June 26, 2012 / BioArray News
Skyline Diagnostics Preps Leukemia Test for US Launch; Gains CE-IVD Mark
March 15, 2011 / BioArray News
Refocusing on Companion Dxs, MPI to Debut Array-based Drug Response-Predictor Test Next Year
September 21, 2010 / BioArray News
Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News